1. Home
  2. NMTC
  3. NMTC News

Latest NeuroOne Medical Technologies Corporation (NMTC) News on July 7, 2025

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System
NMTC

GlobeNewswire

14 days ago

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
NMTC

GlobeNewswire

a month ago

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs
NMTC

GOBankingRates

a month ago

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

3 International Vacations That Are Cheaper Than an iPhone
NMTC

GOBankingRates

a month ago

3 International Vacations That Are Cheaper Than an iPhone

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck
NMTC

GOBankingRates

a month ago

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

This week in Trumponomics: Too bad TACO isn’t true
NMTC

Yahoo Finance

a month ago

This week in Trumponomics: Too bad TACO isn’t true

Starmer says Farage would spook the City and give us Truss 2 – he could be right
NMTC

The Guardian

a month ago

Starmer says Farage would spook the City and give us Truss 2 – he could be right

AI ecosystem isn't just Nvidia: Unlock it further with this ETF
NMTC

Yahoo Finance Video

a month ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?
NMTC

Benzinga

a month ago

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Ford recalls more than 29,000 vehicles in the US, NHTSA says
NMTC

Reuters

a month ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025
NMTC

GlobeNewswire

a month ago

NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025

NeuroOne Medical Technologies Second Quarter 2025 Earnings: Beats Expectations
NMTC

Simply Wall St.

2 months ago

NeuroOne Medical Technologies Second Quarter 2025 Earnings: Beats Expectations

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%
NMTC

GlobeNewswire

2 months ago

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor
NMTC

GlobeNewswire

2 months ago

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

NMTC

Newsfile

2 months ago

NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time
NMTC

GlobeNewswire

2 months ago

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
NMTC

GlobeNewswire

2 months ago

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® Issues Letter to Shareholders
NMTC

GlobeNewswire

3 months ago

NeuroOne® Issues Letter to Shareholders

NeuroOne® OneRF® Technology Success Story Featured on Fox News
NMTC

GlobeNewswire

3 months ago

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Ronald McClurg Spends US$100k On NeuroOne Medical Technologies Stock
NMTC

Simply Wall St.

3 months ago

Ronald McClurg Spends US$100k On NeuroOne Medical Technologies Stock

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock
NMTC

GlobeNewswire

3 months ago

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
NMTC

GlobeNewswire

3 months ago

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update
NMTC

GlobeNewswire

4 months ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace
NMTC

GlobeNewswire

4 months ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace

NeuroOne CEO Joins Today’s Marketplace To Discuss The Latest Treatments for Epilepsy
NMTC

GlobeNewswire

4 months ago

NeuroOne CEO Joins Today’s Marketplace To Discuss The Latest Treatments for Epilepsy

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
NMTC

GlobeNewswire

4 months ago

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
NMTC

GlobeNewswire

4 months ago

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
NMTC

GlobeNewswire

5 months ago

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time
NMTC

GlobeNewswire

5 months ago

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

NeuroOne® Regains Compliance with Nasdaq Listing Requirements
NMTC

GlobeNewswire

5 months ago

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

NeuroOne Reports Record Revenue Boost in Q1 2025
NMTC

TipRanks

6 months ago

NeuroOne Reports Record Revenue Boost in Q1 2025

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million
NMTC

GlobeNewswire

6 months ago

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024
NMTC

GlobeNewswire

6 months ago

NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST
NMTC

GlobeNewswire

6 months ago

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025
NMTC

GlobeNewswire

7 months ago

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time
NMTC

GlobeNewswire

7 months ago

NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
NMTC

ACCESSWIRE

7 months ago

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event
NMTC

ACCESSWIRE

8 months ago

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System
NMTC

GlobeNewswire

8 months ago

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
NMTC

GlobeNewswire

8 months ago

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference
NMTC

GlobeNewswire

9 months ago

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland
NMTC

GlobeNewswire

10 months ago

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference
NMTC

GlobeNewswire

10 months ago

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
NMTC

GlobeNewswire

a year ago

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14
NMTC

GlobeNewswire

a year ago

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility
NMTC

GlobeNewswire

a year ago

NeuroOne® Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility

NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System
NMTC

GlobeNewswire

a year ago

NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation
NMTC

GlobeNewswire

a year ago

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
NMTC

GlobeNewswire

a year ago

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
NMTC

GlobeNewswire

a year ago

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

Favourable Signals For NeuroOne Medical Technologies: Numerous Insiders Acquired Stock
NMTC

Simply Wall St.

a year ago

Favourable Signals For NeuroOne Medical Technologies: Numerous Insiders Acquired Stock

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
NMTC

GlobeNewswire

a year ago

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
NMTC

GlobeNewswire

a year ago

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes

NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
NMTC

GlobeNewswire

a year ago

NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
NMTC

GlobeNewswire

a year ago

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System

NeuroOne® to Participate in the 36th Annual Roth Conference
NMTC

GlobeNewswire

a year ago

NeuroOne® to Participate in the 36th Annual Roth Conference

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NMTC

GlobeNewswire

a year ago

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NeuroOne Medical Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
NMTC

Simply Wall St.

a year ago

NeuroOne Medical Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
NMTC

GlobeNewswire

a year ago

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
NMTC

GlobeNewswire

a year ago

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

HBT Financial (HBT) Reports Q4 Earnings: What Key Metrics Have to Say
NMTC

Zacks

a year ago

HBT Financial (HBT) Reports Q4 Earnings: What Key Metrics Have to Say

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
NMTC

Business Wire

a year ago

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?
NMTC

Simply Wall St.

a year ago

Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?

Issuer Direct Set to Exhibit and Sponsor the 2024 Vancouver Resource Investment Conference
NMTC

ACCESSWIRE

a year ago

Issuer Direct Set to Exhibit and Sponsor the 2024 Vancouver Resource Investment Conference

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream
NMTC

GlobeNewswire

a year ago

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
NMTC

GlobeNewswire

2 years ago

Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million
NMTC

GlobeNewswire

2 years ago

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million

New partnership aims to advance vaccine against MERS coronavirus
NMTC

GlobeNewswire

2 years ago

New partnership aims to advance vaccine against MERS coronavirus

The 3 Most Undervalued Penny Stocks to Buy in December
NMTC

InvestorPlace

2 years ago

The 3 Most Undervalued Penny Stocks to Buy in December

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update
NMTC

GlobeNewswire

2 years ago

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination
NMTC

GlobeNewswire

2 years ago

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination

NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System
NMTC

GlobeNewswire

2 years ago

NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14
NMTC

GlobeNewswire

2 years ago

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

Sidoti Events, LLC's Virtual December Small-Cap Conference
NMTC

ACCESSWIRE

2 years ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

Here's Why We're Watching BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation
NMTC

Simply Wall St.

2 years ago

Here's Why We're Watching BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation

25 Highest Quality Furniture Brands in the World
NMTC

Insider Monkey

2 years ago

25 Highest Quality Furniture Brands in the World

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
NMTC

GlobeNewswire

2 years ago

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NMTC

GlobeNewswire

2 years ago

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript
NMTC

Insider Monkey

2 years ago

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript

METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2023 AND PROVIDES ASSET UPDATES
NMTC

CNW Group

2 years ago

METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2023 AND PROVIDES ASSET UPDATES

Manhattan Bridge Capital's (NASDAQ:LOAN) investors will be pleased with their 18% return over the last five years
NMTC

Simply Wall St.

2 years ago

Manhattan Bridge Capital's (NASDAQ:LOAN) investors will be pleased with their 18% return over the last five years

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System
NMTC

GlobeNewswire

2 years ago

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2023 Earnings Call Transcript
NMTC

Insider Monkey

2 years ago

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2023 Earnings Call Transcript

Share on Social Networks: